ABPI announces new president
This article was originally published in Scrip
Simon Jose, senior vice president and general manager of GlaxoSmithKline UK Pharmaceuticals, will take over as president of the Association of the British Pharmaceutical Industry in April. He will replace Chris Brinsmead, chairman of AstraZeneca UK. Mr Jose will initially serve a term of one year but will be able to stand for re-election for a further 12 months. He said he was pleased represent the industry at an important time for the sector as it was undergoing "considerable and rapid change".
You may also be interested in...
Brazil’s medicines regulator, ANVISA, finally has a new set of rules for the evaluation and marketing authorization of advanced therapy medicines.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.